Alonso, P.L., Sacarlal, J., Aponte, J.J.,

Leach, A., Macete, E., Aide, P., Sigaugue,

B., Milman, J., Mandomando, I.,

Basat, Q., Guinovart, C., Espasa, M.,

Corachan, S., Lievens, M., Navia, M.M.,

Dubios, m., Menendez, C., dubovsky, F.,

cohen, J., Thompson, R. And Ballou,

W.R. (2005). Duration of protection with

RTS,S/AS0: A malaria vaccine in prevention

of Plasmodium falciparum disease in

Mozambican children: single-blind extended

follow-up of a randomised controlled

trial. Lancet 366(9502): 2012-

2018.

Aponte, J.J., Aide, P., Renom, M., Mandomando,

I., Bassat, Q., Sacarial, J.,

manaca, M.N., Lafuente, S., Barbosa, A.,

Leach, A., Lievens, M., Vekemans, J.,

Sigaugue, B., Dubois, M.C., Demoitie,

M.A., Sillman, M., Savarese, B.,

McNeil, J.C., Macete, E., Ballou, W.R.,

Cohen, J. And Alonso, P.L. (2007).

Safety of the RTS,S/AS02D: Candidate

malaria vaccine in infants living in a

highly endemic area of Mozambique: a

double blind randomised controlled Phase

I/IIb trial. Lancet 370: 1543-1551

Aylward, B., Hennessey, K. A., Zagaria, N.,

Olive, J. and Cochi, S. (2000). When is

disease eradicable? 100 years of lessons

learned. American Journal of Public

Health 90:1515–1520.

Baniecki, M.L., Wirth, D.F. and Clardy, J.

(2007). High-throughput Plasmodium falciparum

growth assay for malaria drug

discovery. Antimicrob. Agents Chemotherapy

51: 716–723.

Baruch, D. I., Pasloske, B. L., Singh, H. B.,

Bi, X., Ma, X. C., Feldman, M., Taraschi,

T. F. and Howard, R. J. (1995).

Cloning the P. falciparum gene encoding

PfEMP1, a malarial variant antigen and

adherence receptor on the surface of parasitized

human erythrocytes. Cell 82:77–

87.

Bejon, P., Berkley, J.A., Mwangi, T.,

Ogada, E., Nwangi, I., Maitland, K.,

Williams, T., Anthony, J., Scott, G.,

English, M., Lowe, B.S., Peshu, N.,

Newton, R.J.C. and Marsh, K. (2007).

Defining childhood severe falciparum malaria

for intervention studies. PLoS Medicine

4(8): e251.

Bhattacharjee, S., Hiller, L.N., Konstatinos,

L., Win, J., Kanneganti, T., Young, C.,

Kamoun, S. And Haldar, K. (2006). The

malarial host-targeting signal is conserved

in the Irish potato famine pathogen. PLoS

Pathogens 2: e50

Bouharoun-Tayoun, H., Attanath, P., Sabchareon,

A., Chongsuphajaisiddhi, T.

and Druilhe, P. (1990). Antibodies that

protect humans against Plasmodium falciparum

blood stages do not on their own

inhibit parasite growth and invasion in vitro,

but act in cooperation with monocytes.

Journal of Experimental Medicine

172(6): 1633-1641

Breman, J.G. (2001). The ears of the hippopotamus:

manifestations, determinants and

estimates of the malaria burden. American

Journal of Tropical Medicine & Hygiene

64 (Suppl): 1-11.

CDC information website for malaria.

Available at http://www.cdc.gov/

malaria/.

Chen, Q., Pettersson, F., Vogt, A.M.,

Schmidt, B., Ahuja, S., Litjestrom, P.

And Wahigren, M. (2004). Immunization

with PfEMP1-DBL1a generates antibodies

that disrupt rosettes and protect against the

sequestration of Plasmodium falciparuminfected

erythrocytes. Vaccine 22: 2701-

2712.

Chen, Q., Fernandez, V., Sundstrom, Α.,

Schlichtherle, Μ., Datta, S., Hagblom,

P. and Wahlgren, M. (1998). Developmental

selection of var gene expression in

Plasmodium falciparum. Nature 394: 392

–395.

Daubersies, P., Thomas, A.W., Millet, P.,

Brahimi, K., Langermans, J.A., Ollomo,

B., BenMohamed, L., Slierendregt, B.,

Eling,W., VanBelkum, A., Dubreuil, G.,

Meis, J.F., Guerin-Marchand, C., Cayphas,

S., Cohen, J., Cras-Masse., A.and

Druiine, P. (2000). Protection against

Plasmodium falciparum malaria in chimpanzees

by immunization with the conserved

pre-erythrocytic liver-stage antigen

3. Nature Medicine 6(11): 1258-1263.

de Pontual, L., Poilane, I., Ledeur, F.,

Haouchine, D., Lachassine,

E.,Collignon, A., Le Bras, J. and

Gaudelus, J.(2006). Report of a case of

congenital malaria plasmodium malariae

in France. Journal of Tropical Pediatrics.

52(6): 448-450.

Doolan D.L., Hoffman S.L., Southwood

S.Wentworth, P.A., Sidney, J.,Chesnut,

R.W., Keogh, E., Appella, E., Nutman,

T.B., Lal, A.A., Gordon, D.M., Oloo, A.

and Sette, A.(1997). Degenerate cytotoxic

T-cell epitopes from P. falciparum restricted

by multiple HLA-A and HLA-B

supertype alleles. Immunity 7: 97-112

Ernea, V., Ellis, J., Zavala, F., Arnot,

D.E.,Asavanich, A., Masuda, A., Quakyi,

I. and Nussenzweig, R.S. (1984).

DNA cloning of Plasmodium falciparum

circumsporozoite gene: amino acid sequence

of repetitive epitope. Science 22:

628-630

Epstein, J.E., Giersing, B. and Mullen, G,

Moorthy V, Richie TL. (2007). Malaria

vaccines: are we getting closer? Current

Opinion in Molecular Therapeutics 9(1):

12-24

Fidock, D. A., Nomura, T., Talley, A.K.,

Cooper, R.A.,S. Dzekunov, S.M., Ferdig,

M.T., Ursos, L.M., Sidhu, A.B.,

Naude, B. Deitsch, K.W., Su, X.Z.,

Wootton, J.C., Roepe, P.D. And

Wellems, T. E. (2000). Mutations in the

P. falciparum digestive vacuole transmembrane

protein PfCRT and evidence

for their role in chloroquine resistance.

Molecular Cell 6: 861–871

Freitas-Junior, L.H., Bottius, E., Pirrit,

L.A., Dietsch,K.W., Scheidig, C.,

Guinet, F., Nehrbass, U., Wellems, T.E.

and Scherf, A. (2000). Frequent ectopic

recombination of virulence factor genes in

telomeric chromosome clusters of P. falciparum.

Nature 407: 1018-1022

Genton, B., Betuela, I. and Felger, I. (2002).

A recombinant blood-stage malaria vaccine

reduces Plasmodium falciparum density

and exerts selective pressure on parasite

populations in a Phase 1-2b trial in

Papua New Guinea. Journal of Infectious

Diseases 185: 820-827

Giersing, B.K., Dubovsky, F., Saul, A., Denamur,

F., Minor, P. and Meade, B.

(2006). Potency assay design for adjuvanted

recombinant proteins as malaria

vaccines. Vaccine 24(20): 4264-4270

Good, M.F., Xu, H., Wykes, M. and Engwerda,

C.R.. (2005). Development and

regulation of cell-mediated immune responses

to the blood stages of malaria. Implications

for vaccine research. Annual

Review of Immunology 23: 69-99

Graves, P.M., Doubrovsky, A., Carter, R.,

Eida, S. and Beckers, P. (1990). High

frequency of antibody response to Plasmodium

falciparum gametocyte antigens during

acute malaria infections in Papua New

Guinea highlanders. American Journal of

Tropical Medicine & Hygiene 42: 515-

520

Gupta, S., Snow, R.W., Donnelly,. C.A.,

Marsh, K., and Newbold, C.(1999). Immunity

to non-cerebral severe malaria is

acquired after one or two infections. Nature

Medicine 5(3):340-343

Haynes, J.D., Moch, J.K. and Smoot, D.S.

(2002). Erythrocytic malaria growth or

invasion inhibition assays with emphasis

on suspension culture GIA. Methods in-

Molecular Medicine 72, 535-554

Heppner, D.G., Jr, Kester, K.E., Ockenhouse,

C.F., Tornieporth, N. and Ofori,

O. (2005). Towards an RTS,S-based,

multi-stage, multi-antigen vaccine against

falciparum malaria: progress at the Walter

Reed Army Institute of Research. Vaccine

23(17-18): 2243-2250

Hill, A.V.S., Elvin, J., Willis A.C., Aidoo,

M., Allsopp, C.E., Gotch, F.M., Gao,

X.M., Takiguchi, M., Greenwood, B.M.,

Townsend, A.R., McMichael, A.J. And

Whittle, H.C. (1992). Molecular analysis

of the association of HLA-B53 and resistance

to severe malaria. Nature 360: 434

439

Hoffman, S.L., Goh, L.M., Luke, T.C.,

Schneider, J., Le, T.P., Doolan, D.L.,

Sacci, J., de la Vega, P., Dowler, M.,

Paul, C., Gordon, D.M., Stoute, J.A.,

Church, L.W., Sedegah, M., Heppner,

D.G., Ballou, W.R. and Richie, T.L.

(2002). Protection of humans against malaria

by immunization with radiationattenuated

Plasmodium falciparum sporozoites.

Journal of Infectious Diseases 185

(8): 1155-1164

John, C.C., O'Donnell, R.A., Sumba, P.O.,

Moormann, A.M., de Koning-Ward,

T.F., King, C.L., Kazura, J.W. And

Crab, B.S. (2004). Evidence that invasion

-inhibitory antibodies specific for the 19-

kDa fragment of merozoite surface protein

-1 (MSP-119) can play a protective role

against blood-stage Plasmodium falciparum

infection in individuals in a malaria

endemic area of Africa Journal of Immunology

173: 666-672

Kitchen, A.D and Chiodini, P.L. (2006).

Malaria and Blood Transfusion. Vox

Sang. 90(20): 77-84.

Konate, L., Zwetyenga, J., Rogier, C.,

Bischoff, E., Fontenille, D., Tall, A.,

Spiegel, A., Trape, J.F. and Merceraeu-

Puijalon, O (1999). The epidemiology of

multiple Plasmodium falciparum infections.

5. Variation of Plasmodium falciparum

msp-1 and msp-2 allele prevalence

and of infection complexity in two

neighboring Senegalese villages with different

transmission conditions. Transactions

of Royal Society of Tropical Medicine

& Hygiene 93(suppl):S1/21–S1/28.

Kumar, K.A., Oliveira, G.A., Edelman, R.,

Nardin, E.. and Nussenzweig, V.(2004).

Quantitative Plasmodium sporozoite neutralization

assay (TSNA). Journal of Immunological

Methods 292(1-2): 157-164

Kumar, K.A., Sano, G., Boscardin, S., Nussenzweig,

R.S., Nussenzweig, M.C., Zavala,

F. and Nussenzweig, V. (2006). The

circumsporozoite protein is an immunodominant

protective antigen in irradiated

sporozoites. Nature 444(7121): 937-

940

Kurtis, J.D., Hollingdale, M.R., Luty, A.J.,

Lanar, D.E., Krzych, U. and Duffy, P.E.

(2001). Pre-erythrocytic immunity to

Plasmodium falciparum: the case for an

LSA-1 vaccine. Trends in Parasitology 17

(5): 219-223

Kyes, S., Taylor, H., Craig, A., Marsh, K.

and Newbold, C. (1997). Genomic representation

of var gene sequences in Plasmodium

falciparum field isolates from different

geographic regions. Molecular and

Biochemical Parasitology 87: 235–238.

Lell, B. A. (2007). Randomized, observerblind

trial to compare safety and immunogenicity

of two adjuvanted RTS,S antimalaria

vaccine candidates in Gabonese

children. Presented at: 56th ASTMH Annual

Meeting. Philadelphia, PA, USA, 4-8.

Malaria vaccine technology roadmap

(2006). Retrieved on the 24-09=2010 from

www.malariavaccineroadmap.net/pdfs/

Malaria_Vaccine_TRM_Final.pdf

Malkin, E.M., Durbin, A.P., Diemert, D.J.

Sattabongkot, J., Wu, Y., Miura, K.,

Long, C.A.., Laubert, L., Miles, A.P.,

Wang, J., Stowers, A., Miller, L.H. And

Saul, A. (2005). Phase 1 vaccine trial of

Pvs25H: a transmission blocking vaccine

for Plasmodium vivax malaria. Vaccine 23

(24): 3131-3138

Marsh, K.(1999). Clinical features of malaria.

In: Malaria: Molecular and clinical

aspects (Wahlgren, M. And Perlmann, P.

eds.), Harwood Academic Publishers,

Amsterdam, pp. 87–117.

Marti, M., Good, R. T., Rug, M., Knuepfer,

E. and Cowman, A. F. (2004). Targeting

malaria virulence and remodelling proteins

to the host erythrocyte. Science 306:

1930–1933

Mehta, N.M. and Arnold, J.H. (2004) Mechanical

ventilation in children with acute

respiratory failure. Current Opinion in

Critical Care 10:7-12.

Moorthy, V., Reed, Z. and Smith, P.G.

(2007). WHO Study Group on Measures

of Malaria Vaccine Efficacy. Measurement

of malaria vaccine efficacy in Phase

III trials: report of a WHO consultation.

Vaccine 25(28): 5115-5123.

Mueller, I., Zimmerman, P.A. and Reeder,

J.C. (2007).. Plasmodium malariae and

Plasmodium ovale--the "bashful" malaria

parasites. Trends in Parasitology 23 (6):

278–83.

Mueller, M.S., Renard, A., Boato, F., Vogel,

D., Nargeli, M., Zubriggen, R., Robinson,

J.A. and Pluschke, G. (2003). Induction

of parasite growth-inhibitory antibodies

by a virosomal formulation of a peptidomimetic

of loop I from domain III of

Plasmodium falciparum apical membrane

antigen 1. Infection & Immunity 71(8):

4749-4758

Newbold, C. I. (1999). Antigenic variation in

Plasmodium falciparum: Mechanisms and

consequences. Current Opinion in Microbiology

2: 420– 425.

Nomura, T.J., Carlton, M.R., Baird, J.K.,

del Portillo, H.A., Fryauff, D.J., Rathore,

D., Fidock, D.A., Su, X., Collins,

W.E., McCutchan, T.F., Wooton, J.C.,

and Wellems, T.E. (2001). Evidence for

different mechanisms of chloroquine resistance

in two Plasmodium species that

cause human malaria. Journal of Infectious

Diseases 183: 1653–1661.

Ntoumi, F., Rogier, C., Dieye, A., Trape,

J.F., Millet, P. and Mercereau- Puijalon,

O. (1997). Imbalanced distribution of

Plasmodium falciparum MSP-1 genotypes

related to sickle cell anemia. Molecular

Medicine 3: 581–592.

Nussenzweig, R., Vanderberg, J. and Most,

H. (1969). Protective immunity produced

by the injection of x-irradiated sporozoites

of Plasmodium berghei. IV. Dose response,

specificity and humoral immunity.

Mil. Med. 134(10): 1176-1182

Pizarro, J.C., Vulliez-Le, N.B., Chesne-

Seck, M.L., Collins, C.R., Withers-

Martinez, C.,Hackett, F., Blackman,

M.J., Faber, B.W., Remargue, E.J.,

Kocken, C.H.,Thomas, A.W. and Bentley,

G.A.(2005). Crystal structure of the

malaria vaccine candidate apical membrane

antigen 1. Science 308(5720): 408-

411

Plebanski, M., Lee, E. A. M., Hannan, C.

M., Flanagan, K. L., Gilbert, S. C.,

Gravenor, M. B. and Hill, A. V. S.

(1999). Altered peptide ligands narrow the

repertoire of cellular immune responses by

interfering with T-cell priming. Nature

Medicine 5: 565–571.

Polhemus, M.E. (2006). A Phase IIb randomized,

double-blind, controlled study of the

safety, immunogenicity and proof-ofconcept

of RTS,S/AS02A, and RTS,S/

AS01B, two candidate malaria vaccines in

malaria-experienced adults living in Western

Kenya. Presented at: 55th ASTMH Annual

Meeting. Atlanta, GA, USA, 12-26

Pombo, D.J., Lawrence, G., Hirunpetcharat,

C., Rzepczyk, C., Bryden,

M., Cloonan, N., Anderson, K., Mahakunkijcharoen,

Y., Martin, L.D., Wilson,

D., Elliott, S., Elliott, S., Elsen,

D.P., Weinberg, J.B., Saul, A. and

Good, M.F. (2002). Immunity to malaria

after administration of ultra-low doses of

red cells infected with Plasmodium falciparum.

Lancet 360: 610-617

Raffenot, D., Rogeaux, De Goer, B. and

Zerr, B. (1999). Plasmodium falciparum

malaria acquired by accidental inoculation.

European Journal of Clinical Microbiology

& Infectious Diseases. 18(9): 680-

681

Rieckmann, K.H., Beaudoin, R.L., Cassells,

JS. and Sell, K.W. (1979). Use of attenuated

sporozoites in the immunization of

human volunteers against falciparum malaria.

Bulletin of World Health Organisation

57(Suppl. 1): 261-265

Rogerson, S.J., Hviid, L., Duffy, P.E., Leke,

R.F., Taylor, D.W. (2007). Malaria in

pregnancy: pathogenesis and immunity.

Lancet Infectious Diseases 2: 105-117

Ross and the Discovery that Mosquitoes

Transmit Malaria Parasites". CDC Malaria

website. http://www.cdc.gov/

malaria/history/ross.htm. Retrieved on

2009-03-15.

Rudenko, G. (1999). Genes involved in phenotypic

and antigenic variation in African

trypanosomes and malaria. Current Opinions

in Microbiology 2: 651–656.

Sachs, J. and Malaney, P. (2002). The economic

and social burden of malaria. Nature

415: 680–685

Saeij, J. P., Coller, S., Boyle, J.P., Jerome,

M.E., White, M.W. and Boothroyd, J.C.

(2007). Toxoplasma co-opts host gene expression

by injection of a polymorphic

kinase homologue. Nature 445: 324–327

Sauzet, J.P., Perlaza, B.L., Brahimi, K.,

Daubersies, P. and Druilhe, P.(2001).

DNA immunization by Plasmodium falciparum

liver-stage antigen 3 induces protection

against Plasmodium yoelii sporozoite

challenge. Infect. Immun. 69(2), 1202

-1206

Scherf, A., Hernandez-Viras, R., Buffet, P.,

Bottius, E., Benatar, C., Pouvelle, B.,

Gysin, J. and Lanzer. M. (1998). Antigenic

variation in malaria: in situ switching,

relaxed and mutually exclusive transcription

of var genes during intraerythrocytic

development in Plasmodium

falciparum. EMBO Journal 17: 5418–

5426.

Sharma, V. P. (1996). Re-emergence of malaria

in India. Indian Journal of Medicinal

Research 103: 26–45.

Silvie O, Franetich JF, Charrin S., Mueller,

M.S., Stau, A., Bodescot, M., Rubinstein,

E., Hannoun, L., Charoenvit, Y.,

Kocken, C.H., Thomas, A.W., van

Gemert, G.J., Sauerwein, R.W., Blackman,

M.J., Anders, R.F., Pluschke, G.

and Mazier, D. (2004). A role for apical

membrane antigen 1 during invasion of

hepatocytes by Plasmodium falciparum

sporozoites. Journal of Biological Chemistry

279(10): 9490-9496.

Singh, A.P., Buscaglia, C.A., Wang, Q., Levay,

A., Nussenzweig, D.R., Walker,

J.R., Winzeler, E.A., Fujii, H., Fontoura,

B.M. and Nussenzweig, V. (2007).

Plasmodium circumsporozoite protein promotes

the development of the liver stages

of the parasite. Cell 131(3): 492-504

Smith, J. D., Chitnis, C. E., Craig, A. G.,

Roberts, D. J., Hudson- Taylor, D. E.,

Peterson, D. S., Pinches, R., Newbold, C.

I. and Miller, L. H. (1995). Switches in

expression of Plasmodium falciparum var

genes correlate with changes in antigenic

and cytoadherent phenotypes of inherited

erythrocytes, Cell 82(1): 101-10.

Stewart, V.A., McGrath, S.M., Walsh, D.S.,

Davis, S., Hess, A.S., Ware, L.A., Kester,

K.E., Cummings, J.F., Burge, J.R.,

Voss, G., Delchambre, M., Garcon, N.,

Tang, D.B., Cohen, J.D. and Heppner,

D.G.Jr (2006). Pre-clinical evaluation of

new adjuvant formulations to improve the

immunogenicity of the malaria vaccine

RTS,S/AS02A. Vaccine 24(42-43): 6483-

6492

Stowers, A.W., Kennedy, M.C., Keegan,

B.P., Saul, A., Long, C.A. and Miller,

L.H. (2002). Vaccination of monkeys with

recombinant Plasmodium falciparum apical

membrane antigen 1 confers protection

against blood-stage malaria. Infection &

Immunity 70(12): 6961-6967.

Su, X., Heatwole, V. M., Wertheimer, F.,

Guinet, F., Herrfeldt, J. A., Peterson, D.

S., Ravetch, J.A. and Wellems, T. E.,

(1995). The large and diverse gene family

var encodes proteins involved in cytoadherence

and antigenic variation of Plasmodium

falciparum- infected erythrocytes.

Cell 82: 89–100.

Sun, P., Schwenk, R., White ,K., Stoute,

J.A., Cohen, J., Ballou, W.R., Voss, G.,

Kester, K.E., Heppner, D.C. and

Krzych, U. (2003). Protective immunity

induced with malaria vaccine, RTS,S, is

linked to Plasmodium falciparum circumsporozoite

protein-specific CD4+ and

CD8+ T cells producing IFN-γ. Journal of

Immunology 171(12): 6961-6967

Tarantola, D., Macklin, R., Reed, Z.H.,

Osmanov, S., Stobie, M., Hankins, C.

and Kieny, M.P. (2007). Ethical considerations

related to the provision of care

and treatment in vaccine trials. Vaccine 25

(26): 4863-4874

Taylor, S., Barragan, A., Su, C., Fux, B.,

Fentress, S.J., Tang, K., Beatty, W.L.,

Haii, H.E., Jerome, M., Behnke, M.S.,

White, M., Wootton, J.C. and Sibley,

L.D. (2006). A secreted serine-threonine

kinase determines virulence in the eukaryotic

pathogen Toxoplasma gondii.

Science 314: 1776–1780

Vreden, S.G., Verhave, J.P., Oettinger, T.,

Sauerwein, R.W. and Meuwissen, J.H.

(1991). Phase I clinical trial of a recombinant

malaria vaccine consisting of the circumsporozoite

repeat region of Plasmodium

falciparum coupled to hepatitis B

surface antigen. American Journal of

Tropical Medicine & Hygiene 45(5): 533-

538.

Webster, D.P., Dunachie, S., Vuola, J.M.,

Berthoud, T., Keating, S., Laidlaw, S.M.,

McConkey, S.J., Poulton, I., Andrews, L.,

Andersen, R.F., Bejon, P., Butcher, G.,

Sinden, R., Skinner, M.A., Gilbert, S.C.,

and Hill, A.V. (2005). Enhanced T cellmediated

protection against malaria in human

challenges by using the recombinant

poxviruses FP9 and modified vaccinia virus

Ankara. Proceeddings National Academy of

Science. USA 102(13): 4836-4841

Wellems, T. E., and Plowe, C.V. (2001).

Chloroquine-resistant malaria. Journal of

Infectious Diseases 184: 770–776.

Weller, P.F. (2003). Protozoan infections. In:

Infectious diseases (Dale, D.C. Ed.).

WebMD New York. 651-675.

Wernsdorfer, W. H. (1980). The importance of

malaria in the world. In: Epidemiology,

chemotherapy, morphology, and metabolism

(J. P. Kreier, J.P. ed.), Malaria: . Academic

Press, New York. pp. 1–79

Winzeler, E.A . (2008). Malaria research in the

post-genomic era. Nature 455, 751-756.

Withers, M.R., McKinney, D., Ogutu, B.R.,

Waitumbi, J.N., Milman, J.B., Apollo,

O.J., Allen, O.G., Tucker, K., Soisson,

L.A., Diggs, C., Leach, A., Wittes, J.,

Dubovsky, F., Stewart, V.A., Remich,

S.A., Cohen, J., Ballou, W.R., Holland,

A.C., Lyon, J.A., Angov, E., Stoute, J.A.,

Martin, S.K. And Heppner, D.G. (2007).

Safety and reactogenicity of an MSP-1 malaria

vaccine candidate: a randomized Phase

Ib dose-escalation trial in Kenyan children.

PLoS Clinical Trials 1(7): e32

Wootton, J. C., Feng, X., Ferdig, M. T., Cooper,

R. A., Mu, J., Baruch, D. I., Magill,

A. J. and Su. X. (2002). Genetic diversity

and chloroquine selective sweeps in Plasmodium

falciparum. Nature 418 (6895): 430

-323.

World Health Organization. WHO Fact Sheet

on Malaria. Fact Sheet No 94. World Health

Organization. Available at http://

www.who.int/mediacentre/factsheets/fs094/

en/print.html Retrieved , March 15, 2009.

World Health Organisation. (2010). Guidelines

for the treatment of malaria, (2nd Ed.).

pages: 194.